IRIS
Pizzato, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.896
EU - Europa 469
AS - Asia 139
AF - Africa 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.895
IT - Italia 186
UA - Ucraina 93
FI - Finlandia 55
SG - Singapore 55
CN - Cina 49
SE - Svezia 47
GB - Regno Unito 39
VN - Vietnam 20
DE - Germania 19
TR - Turchia 7
BG - Bulgaria 5
JO - Giordania 5
CZ - Repubblica Ceca 4
FR - Francia 4
RU - Federazione Russa 4
ZA - Sudafrica 4
BR - Brasile 2
EU - Europa 2
IN - India 2
NL - Olanda 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BY - Bielorussia 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
IE - Irlanda 1
LV - Lettonia 1
MU - Mauritius 1
NO - Norvegia 1
Totale 3.517
Salva come PNG Salva come JPEG
Città #
Fairfield 508
Chandler 281
Ashburn 261
Woodbridge 249
Seattle 224
Jacksonville 219
Wilmington 188
Cambridge 176
Houston 159
Ann Arbor 96
Princeton 84
San Mateo 81
Trento 72
New York 38
Singapore 35
Beijing 28
Como 26
San Diego 23
Dearborn 20
Helsinki 20
London 14
Dong Ket 12
San Paolo di Civitate 9
Verona 9
Rome 8
Boardman 7
Izmir 7
Los Angeles 6
Turin 6
Washington 6
Bremen 5
Fremont 5
Sofia 5
Brno 4
Brugherio 4
Düsseldorf 4
Guangzhou 4
Jinan 4
Milan 4
Riva Del Garda 4
Volargne 4
Hefei 3
Irvine 3
Islington 3
Johannesburg 3
Kilburn 3
Munich 3
Prescot 3
Aberdeen 2
Altamura 2
Amsterdam 2
Aparecida de Goiânia 2
Busto Arsizio 2
Cernusco sul Naviglio 2
Lagundo 2
Lyon 2
Nanjing 2
Napoli 2
Norwalk 2
Pisa 2
Tolmin 2
Vicenza 2
Villa Lagarina 2
Arnsberg 1
Baku 1
Baotou 1
Cape Town 1
Changsha 1
Chengdu 1
Chicago 1
Cupertino 1
Des Moines 1
Dublin 1
Ferrara di Monte Baldo 1
Fort Worth 1
Frederiksberg 1
Hebei 1
La Canada Flintridge 1
Lappeenranta 1
Las Vegas 1
Lawrence 1
Minsk 1
Moscow 1
Mountain View 1
New Bedfont 1
Nuremberg 1
Olcenengo 1
Oslo 1
Padova 1
Phoenix 1
Piraeus 1
Quito 1
Redmond 1
Riga 1
San Francisco 1
Scuola 1
Shanghai 1
Southwark 1
Sydney 1
Toronto 1
Totale 3.007
Salva come PNG Salva come JPEG
Nome #
SERINC5 as a new restriction factor for human immunodeficiency virus and murine leukemia virus 140
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins 129
The antagonism of HIV Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor 125
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation 111
The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild 110
Retroviral factors promoting infectivity. 109
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration 103
A bipartite structural organization defines the SERINC family of HIV-1 restriction factors 103
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles 97
Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. 94
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3 93
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists 90
Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry. 86
Galanin pathogenic mutations in temporal lobe epilepsy 86
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. 85
Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tK. 81
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. 81
Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. 79
Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. 78
Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells. 78
Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents 78
A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. 77
Progress with retroviral gene vectors. 75
Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. 73
Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior 73
TRIM5 is an innate immune sensor for the retrovirus capsid lattice. 73
Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. 71
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. 71
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. 68
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. 68
Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5 67
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. 66
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. 65
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. 64
Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. 62
Determination of HPRT mutant frequency and molecular analysis of T-lymphocyte mutants derived from coke-oven workers. 61
Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. 59
The activity of Nef on HIV-1 infectivity. 57
Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26 57
SARS-CoV-2 and the Host Cell: A Tale of Interactions 55
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 49
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. 45
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. 40
Retrovirus vectors. 37
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 26
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity 21
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 18
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity 17
The impact of infection risk communication format on tourism travel intentions during COVID-19 14
Viral particles imaging through evanescent wave scattering in a total internal reflection laser microscope 13
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 13
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 13
Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol 13
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals 11
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity 10
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 9
A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation 2
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample 1
Totale 3.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 292
Totale 18.481
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020840 0 42 57 103 105 68 116 94 117 46 35 57
2020/2021726 9 69 30 96 102 44 48 56 46 74 99 53
2021/2022481 22 32 8 20 12 31 7 106 48 49 59 87
2022/2023607 63 68 6 69 52 87 9 54 113 35 31 20
2023/2024332 20 20 18 20 34 84 21 22 5 13 12 63
2024/202518 17 1 0 0 0 0 0 0 0 0 0 0
Totale 3.650